Physician profile
Daniel J Meara
NPI 1851500789
$28,818.59
in general payments reported to CMS, 2019-2025
10 companies · $4,706 in 2025
The $4,706 reported for 2025 was more than what 97% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,204 · 2020: $3,580 · 2021: $2,176 · 2022: $2,506 · 2023: $5,251 · 2024: $8,396 · 2025: $4,706.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $11K · Travel and Lodging: $6,508 · Food and Beverage: $495.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $11,350.00 |
| Travel and Lodging | $6,507.54 |
| Food and Beverage | $495.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synthes Gmbh | $28,288.85 | 2019-2025 | |
| Salvin Dental Specialties, INC. | $159.11 | 2019 | |
| Nobel Biocare USA | $95.69 | 2019 | |
| Axogen | $73.71 | 2025 | |
| Kls-Martin L.P. | $65.66 | 2025 | |
| Biohorizons Implant Systems INC. | $34.89 | 2024 | Biohorizons |
| Depuy Synthes Sales INC. | $32.67 | 2019-2022 | |
| Medical Device Business Services, INC. | $31.26 | 2024 | Matrixcombo |
| Checkpoint Surgical, INC | $22.72 | 2022 | |
| Geistlich Pharma, North America, INC. | $14.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Meara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.